Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Yuwang Pharmaceutical is a prominent Chinese pharmaceutical and nutraceutical manufacturer specializing in the production of fish oil and softgel capsules. Established in 1989 as a core subsidiary of the Yuwang Group, the company has grown into one of the world's largest production bases for refined fish oil and Omega-3 fatty acids. Its operations span the entire value chain, from raw material refining to the manufacturing of finished dosage forms like softgels, tablets, and hard capsules. The company serves as a major global supplier and contract manufacturer (CMO), maintaining international certifications including GMP, US FDA registration, and TGA approval. Yuwang's product portfolio primarily focuses on cardiovascular health, metabolic support, and general nutritional supplementation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuwang Pharmaceutical.